FGFR
Fibroblast growth factor receptor
FGFR Isoform Specific Products
All Product Categories
-
FGFR Inhibitors
(326)
View all products
-
FGFR Agonists
(4)
View all products
-
FGFR Antagonist
(1)
View all products
-
FGFR Activators
(6)
View all products
-
FGFR Modulators
(3)
View all products
-
FGFR Degraders
(12)
View all products
-
FGFR Control
(1)
View all products
-
FGFR Ligands
(3)
View all products
-
FGFR Proteins
(97)
View all products
-
FGFR-1 Proteins
(20)
View all products
-
FGFR-2 Proteins
(31)
View all products
-
FGFR-3 Proteins
(26)
View all products
-
FGFR-4 Proteins
(18)
View all products
-
FGFR 관련 제품 (374)
관련 제품 (374)
-
Recombinant Proteins (97)
-
Antibodies (11)
-
FGFR Isoform Comparison
-
Lenvatinib
0 ImagesSynonyms: E7080; MK-7902 -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Nintedanib
0 ImagesSynonyms: BIBF 1120; IntedanibNintedanib (BIBF 1120; Intedanib) is an orally active receptor tyrosine kinase inhibitor. Nintedanib inhibits FGFR1-3, PDGFRα/β, and VEGFR1-3 through competitive binding to the ATP pocket, and blocks PI3K/Akt/mTOR phosphorylation. Nintedanib exhibits anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic effects, reducing collagen deposition, fibroblast activation, angiogenesis, airway inflammation and hyperresponsiveness, and cytokine/chemokine expression. Nintedanib ameliorates Bleomycin (HY-108345)-induced lung injury and dystrophic muscle pathology; it also delays tumor growth and prolongs survival, and immune checkpoint blockade enhances its antitumor efficacy. Nintedanib can be used in research on pulmonary fibrosis, cancer, systemic sclerosis, chronic asthma, and rheumatoid arthritis-associated interstitial lung disease. -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Regorafenib
0 ImagesSynonyms: BAY 73-4506 -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Erdafitinib
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Ponatinib
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Ferulic acid
0 ImagesFerulic acid is a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor with IC50s of 3.78 and 12.5 μM for FGFR1 and FGFR2, respectively. -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Heparan Sulfate
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Infigratinib
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Formononetin
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- PD173074
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Pazopanib
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Pemigatinib
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Efruxifermin
0 ImagesSynonyms: AKR-001; AMG-876Efruxifermin is an Fc-FGF21 fusion protein (human IgG1 Fc domain linked to a modified human FGF21). Efruxifermin has prolonged half-life and enhanced receptor affinity compared with native human FGF21. Efruxifermin can be used for the research of non-alcoholic steatohepatitis. -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Futibatinib
0 ImagesSynonyms: TAS-120Futibatinib (TAS-120) is an orally bioavailable, highly selective, and irreversible FGFR inhibitor, with IC50s of 3.9, 1.3, 1.6, and 8.3 nM for FGFR 1-4, respectively. Futibatinib inhibits mutant and wild-type FGFR2 with similar IC50s (wild-type FGFR2=0.9 nM; V5651=1-3 nM; N550H=3.6 nM; E566G=2.4 nM). -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- SU 5402
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Nintedanib esylate
0 ImagesSynonyms: BIBF 1120 esylate; Intedanib esylateNintedanib esylate (BIBF 1120 esylate; Intedanib esylate) is an orally active receptor tyrosine kinase inhibitor. Nintedanib esylate inhibits FGFR1-3, PDGFRα/β, and VEGFR1-3 through competitive binding to the ATP pocket, and blocks PI3K/Akt/mTOR phosphorylation. Nintedanib esylate exhibits anti-inflammatory, antioxidant, anti-apoptotic, and anti-fibrotic effects, reducing collagen deposition, fibroblast activation, angiogenesis, airway inflammation and hyperresponsiveness, and cytokine/chemokine expression. Nintedanib esylate ameliorates Bleomycin (HY-108345)-induced lung injury and dystrophic muscle pathology; it also delays tumor growth and prolongs survival, and immune checkpoint blockade enhances its antitumor efficacy. Nintedanib esylate can be used in research on pulmonary fibrosis, cancer, systemic sclerosis, chronic asthma, and rheumatoid arthritis-associated interstitial lung disease. -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Lenvatinib mesylate
0 ImagesSynonyms: E7080 mesylate; MK-7902 mesylate -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
- Fexagratinib
-
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
bFGF (119-126)
0 ImagesbFGF (119-126) is a ligand of bFGF. The complex formed by bFGF (119-126) and bFGF can bind to FGFR1, while inhibiting the bFGF-FGFR1 interaction, FGFR1 phosphorylation and downstream signaling pathways. Therefore, bFGF (119-126) induces cell apoptosis and inhibits cell proliferation, migration, angiogenesis and metastasis. When conjugated with a carrier, bFGF (119-126) enhances cellular uptake via FGFR-mediated endocytosis and serves as an effective FGFR-targeted ligand. When used in combination with ultrasound and Doxorubicin (HY-15142A), bFGF (119-126) significantly enhances the inhibitory effect on tumors. bFGF (119-126) is applicable to research related to lung cancer, breast cancer, glioblastoma and ovarian cancer. -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
-
Triamcinolone acetonide
0 ImagesTriamcinolone acetonide inhibits basic fibroblast growth factor (bFGF) induced proliferation of retinal endothelial cells. Triamcinolone acetonide reduces chondrocyte viability and leads to cartilage destruction. Triamcinolone acetonide activates macrophage with anti-inflammatory characteristics. Triamcinolone acetonide can be used in the study of diseases such as atopic dermatitis. -
loading...Please select quantity견적 받기
August 31
-
Please select quantity
August 31
견적 받기
loading... -
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
No matching results
Your Search Returned No Results.
Sorry. There is currently no product that acts on isoform Bcl-2, Bcl-W and Bim together.Please
try each isoform separately.